Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV004582621 | SCV005063236 | pathogenic | Mitochondrial trifunctional protein deficiency | 2023-08-16 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exon(s) 13-15 of the HADHB gene. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to disrupt the C-terminus of the protein. This variant has not been reported in the literature in individuals affected with HADHB-related conditions. This variant disrupts a region of the HADHB protein in which other variant(s) (p.Asn389Asp) have been determined to be pathogenic (PMID: 17143551, 21549624, 24664533). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |